ArticleCancer cell international2026

Serum N-glycan NA3Fb identified as a prognostic biomarker of poor outcome in HBV-related hepatocellular carcinoma.

Pengyuan Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.